These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11355694)

  • 21. Immunohistochemical expression of pi class glutathione S-transferase and alpha-fetoprotein in hepatocellular carcinoma and chronic liver disease.
    Yusof YA; Yan KL; Hussain SN
    Anal Quant Cytol Histol; 2003 Dec; 25(6):332-8. PubMed ID: 14714299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
    Wang L; Huang J; Jiang M; Sun L
    J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stem cell and hepatocyte proliferation in hepatitis C cirrhosis and hepatocellular carcinoma: transplant implications.
    Behnke MK; Reimers M; Fisher RA
    Ann Hepatol; 2013 Jan-2014 Feb; 13(1):45-53. PubMed ID: 24378265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of liver cell dysplasia for development of hepatocellular carcinoma in patients with non-cirrhotic and cirrhotic chronic viral hepatitis.
    Libbrecht L; Craninx M; Nevens F; Desmet V; Roskams T
    Histopathology; 2001 Jul; 39(1):66-73. PubMed ID: 11454046
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.
    Pazirandeh S; Khettry U; Gordon FD; Resnick RH; Murray JE; Sheth SG
    Dig Dis Sci; 2007 Jan; 52(1):220-7. PubMed ID: 17160481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genome-Wide Association Study Identifies TLL1 Variant Associated With Development of Hepatocellular Carcinoma After Eradication of Hepatitis C Virus Infection.
    Matsuura K; Sawai H; Ikeo K; Ogawa S; Iio E; Isogawa M; Shimada N; Komori A; Toyoda H; Kumada T; Namisaki T; Yoshiji H; Sakamoto N; Nakagawa M; Asahina Y; Kurosaki M; Izumi N; Enomoto N; Kusakabe A; Kajiwara E; Itoh Y; Ide T; Tamori A; Matsubara M; Kawada N; Shirabe K; Tomita E; Honda M; Kaneko S; Nishina S; Suetsugu A; Hiasa Y; Watanabe H; Genda T; Sakaida I; Nishiguchi S; Takaguchi K; Tanaka E; Sugihara J; Shimada M; Kondo Y; Kawai Y; Kojima K; Nagasaki M; Tokunaga K; Tanaka Y;
    Gastroenterology; 2017 May; 152(6):1383-1394. PubMed ID: 28163062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of colocalization of HBxAg and insulin like growth factor II in the livers of patients with chronic hepatitis B, cirrhosis and hepatocellular carcinoma.
    Seo JH; Kim KW; Murakami S; Park BC
    J Korean Med Sci; 1997 Dec; 12(6):523-31. PubMed ID: 9443091
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunohistochemical localization of endothelin-1/big endothelin-1 in normal liver, liver cirrhosis and hepatocellular carcinoma.
    Suzuki T; Hoshi N; Watanabe K; Kasukawa R; Suzuki T
    Fukushima J Med Sci; 1998 Dec; 44(2):93-105. PubMed ID: 10091381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA measurements in chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Lin HH; Shyu WC; Chen GL; Lin YH; Chen TJ; Liaw YF
    Liver; 1990 Oct; 10(5):313-8. PubMed ID: 2175006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic characterization of hepatocellular carcinoma using nontargeted tissue metabolomics.
    Huang Q; Tan Y; Yin P; Ye G; Gao P; Lu X; Wang H; Xu G
    Cancer Res; 2013 Aug; 73(16):4992-5002. PubMed ID: 23824744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombopoietin levels in serum and liver tissue in patients with chronic viral hepatitis and hepatocellular carcinoma.
    Okubo M; Shiota G; Kawasaki H
    Clin Sci (Lond); 2000 Sep; 99(3):207-14. PubMed ID: 11787473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxia inducible factor 1α in hepatocellular carcinoma with cirrhosis: Association with prognosis.
    Wang D; Zhang X; Lu Y; Wang X; Zhu L
    Pathol Res Pract; 2018 Dec; 214(12):1987-1992. PubMed ID: 30274686
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digital image analysis of the distribution of proliferating cell nuclear antigen in hepatitis C virus-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Lake-Bakaar G; Mazzoccoli V; Ruffini L
    Dig Dis Sci; 2002 Jul; 47(7):1644-8. PubMed ID: 12141830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study on expression of P16 protein in the liver tissue of viral hepatitis].
    Xin S; Wang L; Wang S
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1998 Jun; 12(2):122-4. PubMed ID: 12515187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular Mechanisms Driving Progression of Liver Cirrhosis towards Hepatocellular Carcinoma in Chronic Hepatitis B and C Infections: A Review.
    Kanda T; Goto T; Hirotsu Y; Moriyama M; Omata M
    Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30889843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased expression of hsa_circ_0003570 in hepatocellular carcinoma and its clinical significance.
    Fu L; Wu S; Yao T; Chen Q; Xie Y; Ying S; Chen Z; Xiao B; Hu Y
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28493512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of insulin-like growth factor II in chronic hepatitis B, liver cirrhosis, and hepatocellular carcinoma.
    Seo JH; Park BC
    Gan To Kagaku Ryoho; 1995 Aug; 22 Suppl 3():292-307. PubMed ID: 7661600
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TREM-2 defends the liver against hepatocellular carcinoma through multifactorial protective mechanisms.
    Esparza-Baquer A; Labiano I; Sharif O; Agirre-Lizaso A; Oakley F; Rodrigues PM; Zhuravleva E; O'Rourke CJ; Hijona E; Jimenez-Agüero R; Riaño I; Landa A; La Casta A; Zaki MYW; Munoz-Garrido P; Azkargorta M; Elortza F; Vogel A; Schabbauer G; Aspichueta P; Andersen JB; Knapp S; Mann DA; Bujanda L; Banales JM; Perugorria MJ
    Gut; 2021 Jul; 70(7):1345-1361. PubMed ID: 32907830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered glycosylation, expression of serum haptoglobin and alpha-1-antitrypsin in chronic hepatitis C, hepatitis C induced liver cirrhosis and hepatocellular carcinoma patients.
    Mondal G; Saroha A; Bose PP; Chatterjee BP
    Glycoconj J; 2016 Apr; 33(2):209-18. PubMed ID: 27034286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of salivary N-glycome in HBV-induced chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
    Qin Y; Zhong Y; Ma T; Zhang J; Yang G; Guan F; Li Z; Li B
    Glycoconj J; 2017 Aug; 34(4):523-535. PubMed ID: 28389847
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.